Quinidex Extentabs en es it fr

Quinidex Extentabs Brand names, Quinidex Extentabs Analogs

Quinidex Extentabs Brand Names Mixture

  • No information avaliable

Quinidex Extentabs Chemical_Formula


Quinidex Extentabs RX_link


Quinidex Extentabs fda sheet

Quinidex_Extentabs FDA

Quinidex Extentabs msds (material safety sheet)

Quinidex Extentabs Synthesis Reference

No information avaliable

Quinidex Extentabs Molecular Weight

324.417 g/mol

Quinidex Extentabs Melting Point

174 oC

Quinidex Extentabs H2O Solubility

140 mg/L

Quinidex Extentabs State


Quinidex Extentabs LogP


Quinidex Extentabs Dosage Forms


Quinidex Extentabs Indication

For the treatment of ventricular pre-excitation and cardiac dysrhythmias

Quinidex Extentabs Pharmacology

Quinidine, a hydantoin anticonvulsant, is used alone or with phenobarbital or other anticonvulsants to manage tonic-clonic seizures, psychomotor seizures, neuropathic pain syndromes including diabetic neuropathy, digitalis-induced cardiac arrhythmias, and cardiac arrhythmias associated with QT-interval prolongation.

Quinidex Extentabs Absorption

No information avaliable

Quinidex Extentabs side effects and Toxicity

No information avaliable

Quinidex Extentabs Patient Information

Before prescribing QUINAGLUTE® as prophylaxis against recurrence of atrial fibrillation, the physician should inform the patient of the risks and benefits to be expected. Discussion should include the facts

  • that the goal of therapy will be a reduction (probably not to zero) in the frequency of episodes of atrial fibrillation; and
  • that reduced frequency of fibrillatory episodes may be expected, if achieved, to bring symptomatic benefit; but
  • that no data are available to show that reduced frequency of fibrillatory episodes will reduce the risks of irreversible harm through stroke or death; and in fact
  • that such data as are available suggest that treatment with QUINAGLUTE® is likely to increase the patient's risk of death.

To confirm whether this is the most current prescribing information available on Quinaglute®, or to obtain the most current prescribing information, please call Berlex Laboratories at 1-888-BERLEX-4 (choose option #4, Product Usage Information).

Quinidex Extentabs Organisms Affected

Humans and other mammals